Agios Pharma (AGIO) Tops Q4 EPS by 4c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.58), $0.04 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $30 million versus the consensus estimate of $22.04 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance
• Amtech Systems closes $60 million public stock offering